LIMNW — Liminatus Pharma Inc. Institutional Holders · Q2 2026

Name: Who Owns LIMNW? 24 Institutions Hold $95.4K (Q2 2026)
Creator: ko.io

Who owns Liminatus Pharma Inc. (LIMNW)? 24 institutions reported holding $95,355 in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: Aristeia Capital, L.L.C. ($16,279), Linden Advisors LP ($13,678), Saba Capital Management, L.P. ($11,910).

Rank	Institution	Value	Shares	Change
1	ARISTEIA CAPITAL, L.L.C.	$16,279	319,510	Hold
2	Linden Advisors LP	$13,678	268,199	Hold
3	Saba Capital Management, L.P.	$11,910	233,761	Hold
4	MOORE CAPITAL MANAGEMENT, LP	$9,375	125,000	Hold
5	MMCAP International Inc. SPC	$8,381	111,745	Hold
6	Polar Asset Management Partners Inc.	$6,257	122,688	Hold
7	MILLENNIUM MANAGEMENT LLC	$5,296	70,616	Hold
8	D. E. Shaw & Co., Inc.	$2,934	83,353	Hold
9	TORONTO DOMINION BANK	$2,633	35,100	Hold
10	LMR Partners LLP	$2,247	29,961	Hold
11	Arena Capital Advisors, LLC- CA	$2,187	29,166	Hold
12	Blue Owl Capital Holdings LP	$2,000	50,000	Hold
13	Periscope Capital Inc.	$1,980	30,000	Trimmed
14	JANE STREET GROUP, LLC	$1,821	24,274	Hold
15	Limestone Investment Advisors LP	$1,692	22,562	Hold
16	GTS SECURITIES LLC	$1,570	20,929	Trimmed
17	SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1,317	17,562	New
18	WOLVERINE ASSET MANAGEMENT LLC	$1,048	13,976	Trimmed
19	FLOW TRADERS U.S. LLC	$1,000	13,110	Hold
20	Virtu Financial LLC	$1,000	10,805	New
21	UBS Group AG	$338	4,507	Hold
22	DUPONT CAPITAL MANAGEMENT CORP	$318	6,250	Hold
23	HGC Investment Management Inc.	$94	1,250	Hold
24	Clear Street Group Inc.	$0	0	Exited

Source: SEC Form 13F filings · as of 2026-06-30